Klinika za psihijatriju Vrapce
- Address
- lock Available on a paid plan
Nervous System Diseases
The Department for Biological Psychiatry and Psychogeriatrics at Klinika za psihijatriju Vrapce concentrates on neurodegenerative conditions that affect the brain’s structure and function.
- Evaluation of agitation in patients with Alzheimer’s dementia
- Study of psychosis linked to Alzheimer’s disease
- Assessment of cognitive decline in mild to moderate Alzheimer’s disease
- Investigation of long‑term safety of novel agents for cognitive impairment in Alzheimer’s patients
These trials aim to test new therapies that reduce behavioral symptoms, improve cognition, and verify long‑term tolerability in elderly populations.
Behavioral Disciplines and Activities
Research here targets disruptive behaviors that compromise daily living and caregiver burden.
- Trials addressing agitation associated with Alzheimer’s dementia
- Interventions for mania in Bipolar‑I disorder
- Adjunctive treatment of tardive dyskinesia in individuals with schizophrenia or related mood disorders
- Evaluation of agents for psychosis associated with Alzheimer’s disease
The purpose is to identify effective medications that calm agitation, control manic episodes, and lessen involuntary movements, thereby enhancing patient safety and quality of life.
Mental Disorders
The site conducts extensive work on core psychiatric illnesses that require long‑term management.
- Studies on symptom relief in schizophrenia
- Evaluation of acute treatment for Manic episodes in Bipolar I Disorder
- Adjunctive therapy trials for Major Depressive Disorder
- Research on overlapping conditions such as schizoaffective disorder
Objectives include testing novel compounds for efficacy, monitoring safety, and improving overall functional outcomes for patients with severe mental illness.
Psychological Phenomena
This field explores underlying mental processes that manifest as clinical symptoms.
- Measurement of agitation using standardized inventories
- Quantification of psychosis severity through clinician‑rated scales
- Assessment of cognitive impairment and global functioning in dementia
- Monitoring of motor disturbances such as tardive dyskinesia
The trials seek to refine diagnostic criteria, evaluate therapeutic impact on these phenomena, and support better clinical decision‑making.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 60 other sites in Croatia
Therapeutic Area Benchmark — Croatia
Select a therapeutic area to compare against other sites in Croatia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Croatia
Market Share
Country: Croatia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinika za psihijatriju Vrapce
lock Showing 1 of 16 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for the Treatment of Cognitive Impairment Associated with Mild to Moderate Alzheimer’s Disease (MINDSET 1) | Bristol-Myers Squibb Services Unlimited Company | Phase III | Recruiting | Nov 2025 | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Trospium Chloride | 5 | Unknown | 2024-05-09 | 2025-11-18 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.